Correlation of Scheimpflug densitometry changes with clinical outcomes after corneal crosslinking

J Cataract Refract Surg. 2018 Aug;44(8):993-1002. doi: 10.1016/j.jcrs.2018.05.016.

Abstract

Purpose: To characterize changes in densitometry after corneal crosslinking (CXL) and correlate it with visual outcomes.

Setting: Tertiary referral academic medical center, New York, New York, USA.

Design: Retrospective case series.

Methods: Patients with progressive keratoconus or post-laser in situ keratomileusis ectasia had CXL following the Dresden protocol. The corrected distance visual acuity (CDVA) and Pentacam imaging were obtained at baseline and follow-up visits.

Results: Fifty-seven patients were followed for a mean of 15 months (range 1 to 24 months) after CXL. The CDVA improved significantly from baseline to 6, 12, 18, and 24 months postoperatively. The change in densitometry of the mid-stromal layer, 2.0 to 6.0 mm annulus, at 6 months was correlated with the improvement in CDVA at 6, 12, and 24 months (all P < .10). The increase in densitometry of the mid-stromal layer, centermost 0.0 to 2.0 mm annulus, at 6 months was significantly associated with the decrease in maximum keratometry (K) at 6 and 12 months (both P < .05). Last, the change in densitometry at 6 months was significantly correlated with the decrease in specific higher-order aberrations (HOAs) (P < .05).

Conclusions: Although the greatest and most durable post-CXL densitometry change was in the anterior layer, the degree of increased densitometry haze in the mid-stromal layer was most associated with and possibly predictive of improvement in CDVA, maximum K, and HOAs. The persistence of corneal haze at 6 months, measured by increased densitometry, might be a prognostic marker for CXL effectiveness.

MeSH terms

  • Adult
  • Aged
  • Collagen / metabolism
  • Corneal Stroma / physiopathology*
  • Cross-Linking Reagents / therapeutic use
  • Densitometry / methods*
  • Female
  • Humans
  • Keratoconus / drug therapy*
  • Keratoconus / physiopathology
  • Male
  • Middle Aged
  • Photochemotherapy / methods*
  • Photosensitizing Agents / therapeutic use
  • Predictive Value of Tests
  • Retrospective Studies
  • Riboflavin / therapeutic use
  • Visual Acuity / physiology

Substances

  • Cross-Linking Reagents
  • Photosensitizing Agents
  • Collagen
  • Riboflavin